| Biomarker ID | 1397 |
| PMID | 24737792 |
| Year | 2014 |
| Biomarker | miR-452 |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Downregulated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: cell development; nervous system development; regulation of signaling; DNA-binding transcription factor activity, RNA polymerase II-specific; cell projection organization |
| Experiment | Prostate Cancer Vs Non Malignant |
| Type of Biomarker | Diagnostic |
| Cohort | 14 nonmalignant and 36 prostate cancer samples were selected for analysis. Microarray data from a distinct set of 10 nonmalignant and 15 prostate cancer samples were also included. qRT-PCR analysis of an independent set of 27 nonmalignant and 80 prostate cancer samples |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.000494 |
| Method Used | Training: Microarray; Validation: qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | NA |